APO Research
Talk to an analyst

APO RESEARCH · REPORT

Automatic Insulin Dosing Device

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Automatic Insulin Dosing Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026195 pages

Choose your research edition.

Industry ResearchAutomatic Insulin Dosing Device Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Automatic Insulin Dosing Device Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Automatic Insulin Dosing Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Automatic Insulin Dosing Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Automatic Insulin Dosing Device Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Automatic Insulin Dosing Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Automatic Insulin Dosing Device include Admetsys, Beta Bionics, Bigfoot Biomedical, Defymed, Dexcom, Insulet, Micro Tech Medical, Tandem Diabetes Care and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Automatic Insulin Dosing Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Automatic Insulin Dosing Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Automatic Insulin Dosing Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Automatic Insulin Dosing Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Automatic Insulin Dosing Device Segment by Company

Admetsys

Beta Bionics

Bigfoot Biomedical

Defymed

Dexcom

Insulet

Micro Tech Medical

Tandem Diabetes Care

Medtronic

Abbott

Automatic Insulin Dosing Device Segment by Type

Threshold Suspended Device Systems

Hybrid Closed-loop APDS

Other

Automatic Insulin Dosing Device Segment by Application

Hospital

Clinic

Home Care

Others

Automatic Insulin Dosing Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Insulin Dosing Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automatic Insulin Dosing Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Insulin Dosing Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Automatic Insulin Dosing Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Automatic Insulin Dosing Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Automatic Insulin Dosing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Automatic Insulin Dosing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Automatic Insulin Dosing Device Industry Trends Table 2. Automatic Insulin Dosing Device Industry Drivers Table 3. Automatic Insulin Dosing Device Industry Opportunities and Challenges Table 4. Automatic Insulin Dosing Device Industry Restraints Table 5. Global Automatic Insulin Dosing Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Automatic Insulin Dosing Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Automatic Insulin Dosing Device Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Automatic Insulin Dosing Device Sales Market Share by Manufacturers Table 9. Global Automatic Insulin Dosing Device Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Automatic Insulin Dosing Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Automatic Insulin Dosing Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Automatic Insulin Dosing Device Manufacturers, Product Type & Application Table 13. Global Automatic Insulin Dosing Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Automatic Insulin Dosing Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Threshold Suspended Device Systems Table 17. Major Manufacturers of Hybrid Closed-loop APDS Table 18. Major Manufacturers of Other Table 19. Global Automatic Insulin Dosing Device Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Automatic Insulin Dosing Device Sales by Type (2021-2026) & (k units) Table 21. Global Automatic Insulin Dosing Device Sales by Type (2027-2032) & (k units) Table 22. Global Automatic Insulin Dosing Device Sales Market Share by Type (2021-2026) Table 23. Global Automatic Insulin Dosing Device Sales Market Share by Type (2027-2032) Table 24. Global Automatic Insulin Dosing Device Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Automatic Insulin Dosing Device Revenue by Type (2021-2026) & (k units) Table 26. Global Automatic Insulin Dosing Device Revenue by Type (2027-2032) & (k units) Table 27. Global Automatic Insulin Dosing Device Revenue Market Share by Type (2021-2026) Table 28. Global Automatic Insulin Dosing Device Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Home Care Table 32. Major Manufacturers of Others Table 33. Global Automatic Insulin Dosing Device Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Automatic Insulin Dosing Device Sales by Application (2021-2026) & (k units) Table 35. Global Automatic Insulin Dosing Device Sales by Application (2027-2032) & (k units) Table 36. Global Automatic Insulin Dosing Device Sales Market Share by Application (2021-2026) Table 37. Global Automatic Insulin Dosing Device Sales Market Share by Application (2027-2032) Table 38. Global Automatic Insulin Dosing Device Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Automatic Insulin Dosing Device Revenue by Application (2021-2026) & (k units) Table 40. Global Automatic Insulin Dosing Device Revenue by Application (2027-2032) & (k units) Table 41. Global Automatic Insulin Dosing Device Revenue Market Share by Application (2021-2026) Table 42. Global Automatic Insulin Dosing Device Revenue Market Share by Application (2027-2032) Table 43. Global Automatic Insulin Dosing Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Automatic Insulin Dosing Device Sales by Region (2021-2026) & (k units) Table 45. Global Automatic Insulin Dosing Device Sales Market Share by Region (2021-2026) Table 46. Global Automatic Insulin Dosing Device Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Automatic Insulin Dosing Device Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Automatic Insulin Dosing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 50. North America Automatic Insulin Dosing Device Sales by Country (2027-2032) & (k units) Table 51. Europe Automatic Insulin Dosing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 53. Europe Automatic Insulin Dosing Device Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Automatic Insulin Dosing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Automatic Insulin Dosing Device Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Automatic Insulin Dosing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Automatic Insulin Dosing Device Sales by Country (2027-2032) & (k units) Table 60. Global Automatic Insulin Dosing Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Automatic Insulin Dosing Device Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Automatic Insulin Dosing Device Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Automatic Insulin Dosing Device Revenue Market Share by Region (2021-2026) Table 64. Global Automatic Insulin Dosing Device Revenue Market Share by Region (2027-2032) Table 65. Admetsys Company Information Table 66. Admetsys Business Overview Table 67. Admetsys Automatic Insulin Dosing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Admetsys Automatic Insulin Dosing Device Product Portfolio Table 69. Admetsys Recent Development Table 70. Beta Bionics Company Information Table 71. Beta Bionics Business Overview Table 72. Beta Bionics Automatic Insulin Dosing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Beta Bionics Automatic Insulin Dosing Device Product Portfolio Table 74. Beta Bionics Recent Development Table 75. Bigfoot Biomedical Company Information Table 76. Bigfoot Biomedical Business Overview Table 77. Bigfoot Biomedical Automatic Insulin Dosing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bigfoot Biomedical Automatic Insulin Dosing Device Product Portfolio Table 79. Bigfoot Biomedical Recent Development Table 80. Defymed Company Information Table 81. Defymed Business Overview Table 82. Defymed Automatic Insulin Dosing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Defymed Automatic Insulin Dosing Device Product Portfolio Table 84. Defymed Recent Development Table 85. Dexcom Company Information Table 86. Dexcom Business Overview Table 87. Dexcom Automatic Insulin Dosing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Dexcom Automatic Insulin Dosing Device Product Portfolio Table 89. Dexcom Recent Development Table 90. Insulet Company Information Table 91. Insulet Business Overview Table 92. Insulet Automatic Insulin Dosing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Insulet Automatic Insulin Dosing Device Product Portfolio Table 94. Insulet Recent Development Table 95. Micro Tech Medical Company Information Table 96. Micro Tech Medical Business Overview Table 97. Micro Tech Medical Automatic Insulin Dosing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Micro Tech Medical Automatic Insulin Dosing Device Product Portfolio Table 99. Micro Tech Medical Recent Development Table 100. Tandem Diabetes Care Company Information Table 101. Tandem Diabetes Care Business Overview Table 102. Tandem Diabetes Care Automatic Insulin Dosing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Tandem Diabetes Care Automatic Insulin Dosing Device Product Portfolio Table 104. Tandem Diabetes Care Recent Development Table 105. Medtronic Company Information Table 106. Medtronic Business Overview Table 107. Medtronic Automatic Insulin Dosing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Medtronic Automatic Insulin Dosing Device Product Portfolio Table 109. Medtronic Recent Development Table 110. Abbott Company Information Table 111. Abbott Business Overview Table 112. Abbott Automatic Insulin Dosing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Abbott Automatic Insulin Dosing Device Product Portfolio Table 114. Abbott Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Automatic Insulin Dosing Device Distributors List Table 118. Automatic Insulin Dosing Device Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Automatic Insulin Dosing Device Product Image Figure 2. Global Automatic Insulin Dosing Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automatic Insulin Dosing Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Automatic Insulin Dosing Device Sales (2021-2032) & (k units) Figure 5. Global Automatic Insulin Dosing Device Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Automatic Insulin Dosing Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Threshold Suspended Device Systems Image Figure 9. Hybrid Closed-loop APDS Image Figure 10. Other Image Figure 11. Global Automatic Insulin Dosing Device Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Automatic Insulin Dosing Device Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Automatic Insulin Dosing Device Sales Market Share by Type (2021-2032) Figure 14. Global Automatic Insulin Dosing Device Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Automatic Insulin Dosing Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Automatic Insulin Dosing Device Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Home Care Image Figure 20. Others Image Figure 21. Global Automatic Insulin Dosing Device Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Automatic Insulin Dosing Device Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Automatic Insulin Dosing Device Sales Market Share by Application (2021-2032) Figure 24. Global Automatic Insulin Dosing Device Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Automatic Insulin Dosing Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Automatic Insulin Dosing Device Revenue Market Share by Application (2021-2032) Figure 27. North America Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Automatic Insulin Dosing Device Sales Market Share by Country (2021-2032) Figure 29. U.S. Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Automatic Insulin Dosing Device Sales Market Share by Country (2021-2032) Figure 34. Germany Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Automatic Insulin Dosing Device Sales Market Share by Country (2021-2032) Figure 41. China Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Automatic Insulin Dosing Device Sales Market Share by Country (2021-2032) Figure 49. Brazil Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Automatic Insulin Dosing Device Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Automatic Insulin Dosing Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Automatic Insulin Dosing Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Automatic Insulin Dosing Device Revenue (2021-2032) & (US$ Million) Figure 60. North America Automatic Insulin Dosing Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Automatic Insulin Dosing Device Revenue (2021-2032) & (US$ Million) Figure 62. Europe Automatic Insulin Dosing Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Automatic Insulin Dosing Device Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Automatic Insulin Dosing Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Automatic Insulin Dosing Device Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Automatic Insulin Dosing Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Automatic Insulin Dosing Device Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Automatic Insulin Dosing Device Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Threshold Suspended Device Systems
  • Hybrid Closed-loop APDS
  • Other
Applications
  • Hospital
  • Clinic
  • Home Care
  • Others
Companies covered
  • Admetsys
  • Beta Bionics
  • Bigfoot Biomedical
  • Defymed
  • Dexcom
  • Insulet
  • Micro Tech Medical
  • Tandem Diabetes Care
  • Medtronic
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Automatic Insulin Dosing Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Automatic Insulin Dosing Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Automatic Insulin Dosing Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Automatic Insulin Dosing Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Automatic Insulin Dosing Device Market Dynamics
  1. 2.1 Automatic Insulin Dosing Device Industry Trends
  2. 2.2 Automatic Insulin Dosing Device Industry Drivers
  3. 2.3 Automatic Insulin Dosing Device Industry Opportunities and Challenges
  4. 2.4 Automatic Insulin Dosing Device Industry Restraints
3 Automatic Insulin Dosing Device Market by Manufacturers
  1. 3.1 Global Automatic Insulin Dosing Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Automatic Insulin Dosing Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Automatic Insulin Dosing Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Automatic Insulin Dosing Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Automatic Insulin Dosing Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Automatic Insulin Dosing Device Manufacturers, Product Type & Application
  7. 3.7 Global Automatic Insulin Dosing Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Automatic Insulin Dosing Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Automatic Insulin Dosing Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Automatic Insulin Dosing Device Tier 1, Tier 2, and Tier 3
4 Automatic Insulin Dosing Device Market by Type
  1. 4.1 Automatic Insulin Dosing Device Type Introduction
  2. 4.1.1 Threshold Suspended Device Systems
  3. 4.1.2 Hybrid Closed-loop APDS
  4. 4.1.3 Other
  5. 4.2 Global Automatic Insulin Dosing Device Sales by Type
  6. 4.2.1 Global Automatic Insulin Dosing Device Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Automatic Insulin Dosing Device Sales by Type (2021-2032)
  8. 4.2.3 Global Automatic Insulin Dosing Device Sales Market Share by Type (2021-2032)
  9. 4.3 Global Automatic Insulin Dosing Device Revenue by Type
  10. 4.3.1 Global Automatic Insulin Dosing Device Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Automatic Insulin Dosing Device Revenue by Type (2021-2032)
  12. 4.3.3 Global Automatic Insulin Dosing Device Revenue Market Share by Type (2021-2032)
5 Automatic Insulin Dosing Device Market by Application
  1. 5.1 Automatic Insulin Dosing Device Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Home Care
  5. 5.1.4 Others
  6. 5.2 Global Automatic Insulin Dosing Device Sales by Application
  7. 5.2.1 Global Automatic Insulin Dosing Device Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Automatic Insulin Dosing Device Sales by Application (2021-2032)
  9. 5.2.3 Global Automatic Insulin Dosing Device Sales Market Share by Application (2021-2032)
  10. 5.3 Global Automatic Insulin Dosing Device Revenue by Application
  11. 5.3.1 Global Automatic Insulin Dosing Device Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Automatic Insulin Dosing Device Revenue by Application (2021-2032)
  13. 5.3.3 Global Automatic Insulin Dosing Device Revenue Market Share by Application (2021-2032)
6 Global Automatic Insulin Dosing Device Sales by Region
  1. 6.1 Global Automatic Insulin Dosing Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Automatic Insulin Dosing Device Sales by Region (2021-2032)
  3. 6.2.1 Global Automatic Insulin Dosing Device Sales by Region (2021-2026)
  4. 6.2.2 Global Automatic Insulin Dosing Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Automatic Insulin Dosing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Automatic Insulin Dosing Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Automatic Insulin Dosing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Automatic Insulin Dosing Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Automatic Insulin Dosing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Automatic Insulin Dosing Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Automatic Insulin Dosing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Automatic Insulin Dosing Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Automatic Insulin Dosing Device Revenue by Region
  1. 7.1 Global Automatic Insulin Dosing Device Revenue by Region
  2. 7.1.1 Global Automatic Insulin Dosing Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Automatic Insulin Dosing Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Automatic Insulin Dosing Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Automatic Insulin Dosing Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Automatic Insulin Dosing Device Revenue (2021-2032)
  8. 7.2.2 North America Automatic Insulin Dosing Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Automatic Insulin Dosing Device Revenue (2021-2032)
  11. 7.3.2 Europe Automatic Insulin Dosing Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Automatic Insulin Dosing Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Automatic Insulin Dosing Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Automatic Insulin Dosing Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Automatic Insulin Dosing Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Admetsys
  2. 8.1.1 Admetsys Company Information
  3. 8.1.2 Admetsys Business Overview
  4. 8.1.3 Admetsys Automatic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Admetsys Automatic Insulin Dosing Device Product Portfolio
  6. 8.1.5 Admetsys Recent Developments
  7. 8.2 Beta Bionics
  8. 8.2.1 Beta Bionics Company Information
  9. 8.2.2 Beta Bionics Business Overview
  10. 8.2.3 Beta Bionics Automatic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beta Bionics Automatic Insulin Dosing Device Product Portfolio
  12. 8.2.5 Beta Bionics Recent Developments
  13. 8.3 Bigfoot Biomedical
  14. 8.3.1 Bigfoot Biomedical Company Information
  15. 8.3.2 Bigfoot Biomedical Business Overview
  16. 8.3.3 Bigfoot Biomedical Automatic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bigfoot Biomedical Automatic Insulin Dosing Device Product Portfolio
  18. 8.3.5 Bigfoot Biomedical Recent Developments
  19. 8.4 Defymed
  20. 8.4.1 Defymed Company Information
  21. 8.4.2 Defymed Business Overview
  22. 8.4.3 Defymed Automatic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Defymed Automatic Insulin Dosing Device Product Portfolio
  24. 8.4.5 Defymed Recent Developments
  25. 8.5 Dexcom
  26. 8.5.1 Dexcom Company Information
  27. 8.5.2 Dexcom Business Overview
  28. 8.5.3 Dexcom Automatic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dexcom Automatic Insulin Dosing Device Product Portfolio
  30. 8.5.5 Dexcom Recent Developments
  31. 8.6 Insulet
  32. 8.6.1 Insulet Company Information
  33. 8.6.2 Insulet Business Overview
  34. 8.6.3 Insulet Automatic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Insulet Automatic Insulin Dosing Device Product Portfolio
  36. 8.6.5 Insulet Recent Developments
  37. 8.7 Micro Tech Medical
  38. 8.7.1 Micro Tech Medical Company Information
  39. 8.7.2 Micro Tech Medical Business Overview
  40. 8.7.3 Micro Tech Medical Automatic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Micro Tech Medical Automatic Insulin Dosing Device Product Portfolio
  42. 8.7.5 Micro Tech Medical Recent Developments
  43. 8.8 Tandem Diabetes Care
  44. 8.8.1 Tandem Diabetes Care Company Information
  45. 8.8.2 Tandem Diabetes Care Business Overview
  46. 8.8.3 Tandem Diabetes Care Automatic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tandem Diabetes Care Automatic Insulin Dosing Device Product Portfolio
  48. 8.8.5 Tandem Diabetes Care Recent Developments
  49. 8.9 Medtronic
  50. 8.9.1 Medtronic Company Information
  51. 8.9.2 Medtronic Business Overview
  52. 8.9.3 Medtronic Automatic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medtronic Automatic Insulin Dosing Device Product Portfolio
  54. 8.9.5 Medtronic Recent Developments
  55. 8.10 Abbott
  56. 8.10.1 Abbott Company Information
  57. 8.10.2 Abbott Business Overview
  58. 8.10.3 Abbott Automatic Insulin Dosing Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abbott Automatic Insulin Dosing Device Product Portfolio
  60. 8.10.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Automatic Insulin Dosing Device Value Chain Analysis
  2. 9.1.1 Automatic Insulin Dosing Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Automatic Insulin Dosing Device Production Mode & Process
  6. 9.2 Automatic Insulin Dosing Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Automatic Insulin Dosing Device Distributors
  9. 9.2.3 Automatic Insulin Dosing Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst